Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MyMD-1 by MyMD Pharmaceuticals for Sarcopenia: Likelihood of Approval
MyMD-1 is under clinical development by MyMD Pharmaceuticals and currently in Phase II for Sarcopenia. According to GlobalData, Phase II...